Showing results (251-260 of 441) with videos related to

Sort By:
Pageof 45
Neuro-Oncology|December 7, 2013
Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiationChristian L Barney, Aaron P Brown, David R Grosshans, et al.
Biophysical Journal|November 15, 2020
A Novel In Vitro Device to Deliver Induced Electromagnetic Fields to Cell and Tissue CulturesRea Ravin, Teddy X Cai, Randall H Pursley, et al.
Medrxiv : the Preprint Server for Health Sciences|January 16, 2026
Managing Cancer and Living Meaningfully Therapy Delivered as a novel remote intervention in individuals diagnosed with a Primary Central Nervous System TumorAlvina Acquaye-Mallory, Gary Rodin, Madhura Managoli, et al.
Neuro-Oncology|October 21, 2020
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymomaMark R Gilbert, Ying Yuan, Jimin Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 1, 2024
rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic CellsHerui Wang, Rogelio Medina, Juan Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain MetastasesIshwaria M Subbiah, Xiudong Lei, Jeffrey S Weinberg, et al.
Scientific Reports|April 28, 2022
Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patientsAshish H Shah, Vaidya Govindarajan, Tara T Doucet-O'Hare, et al.
Neuro-Oncology|May 6, 2024
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020Mackenzie Price, Corey Neff, Nitin Nagarajan, et al.
Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
Neurosurgery|July 17, 2018
Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype GlioblastomaDrew Pratt, Gifty Dominah, Graham Lobel, et al.
Pageof 45